Selenoprotein T protects against cisplatin‐induced acute kidney injury through suppression of oxidative stress and apoptosis

Abstract Previously, selenoprotein T (SelT) expression was shown to be induced in nervous, endocrine, and metabolic tissues during ontogenetic and regenerative processes. However, whether SelT plays a critical role in renal diseases remains unclear. Here, we explored the role of SelT in cisplatin‐induced acute kidney injury (AKI). Results revealed that SelT was highly expressed in renal tubules, but its expression was significantly reduced in cisplatin‐induced AKI. Importantly, knocking down of SelT expression in kidney cells in vitro resulted in cisplatin‐induced cell apoptosis, as indicated by the elevation of cleaved‐PARP and Bax expression, Caspase‐3 activity, and number of TUNEL‐positive cells. Moreover, SelT silencing‐induced reactive oxygen species (ROS) production, accompanied by a decrease in intracellular superoxide dismutase (SOD) and catalase (CAT) activity and increase in malondialdehyde (MDA) content. Notably, the protein and mRNA levels of Nox4 were increased in response to SelT downregulation. Furthermore, suppression of Nox4 expression by GKT137831 partially alleviated SelT knockdown‐induced ROS generation and cell apoptosis in cisplatin‐treated kidney cells. Taken together, our findings provide the first evidence that SelT protects against cisplatin‐induced AKI by suppression of oxidative stress and apoptosis.